Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Biocorrx Inc. (BICX) had Consolidated Net Income/Loss of $-1.00M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.09M |
|
$-0.96M |
|
$0.14M |
|
$-0.06M |
|
$1.55M |
|
$-1.47M |
|
$0.46M |
|
$-1.00M |
|
$-1.00M |
|
$-1.00M |
|
$-1.00M |
|
|
Consolidated Net Income/Loss |
$-1.00M |
$-1.00M |
|
$-1.47M |
|
$-1.33M |
|
29.22M |
|
29.22M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$0.62M |
|
-- |
|
$1.28M |
|
$1.91M |
|
$8.85M |
|
$5.08M |
|
$5.52M |
|
$14.38M |
|
$-12.49M |
|
$-13.58M |
|
$-12.47M |
|
29.67M |
|
| Cash Flow Statement Financials | |
$-0.87M |
|
-- |
|
$0.76M |
|
$0.14M |
|
$0.02M |
|
$-0.12M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.07 |
|
-- |
|
-- |
|
-0.69 |
|
-0.57 |
|
-64.79% |
|
-1665.95% |
|
-1665.95% |
|
-- |
|
-1138.69% |
|
-1096.71% |
|
$-0.87M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
3.33 |
|
0.52 |
|
174.24 |
|
8.02% |
|
7.38% |
|
-52.52% |
|
13.56% |
|
$-0.42 |
|
$-0.03 |
|
$-0.03 |
|